B

Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613

Watchlist Manager
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Watchlist
Price: 8.05 HKD 0.63%
Market Cap: 6.7B HKD
Have any thoughts about
Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Write Note

Beijing Tong Ren Tang Chinese Medicine Co Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Beijing Tong Ren Tang Chinese Medicine Co Ltd
Cash Equivalents Peer Comparison

Comparables:
G
512
U
3933
1177
C
3320
H
13

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
B
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Cash Equivalents
HK$1.7B
CAGR 3-Years
-4%
CAGR 5-Years
33%
CAGR 10-Years
13%
G
Grand Pharmaceutical Group Ltd
HKEX:512
Cash Equivalents
HK$734.5m
CAGR 3-Years
-32%
CAGR 5-Years
-5%
CAGR 10-Years
10%
U
United Laboratories International Holdings Ltd
HKEX:3933
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sino Biopharmaceutical Ltd
HKEX:1177
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Cash Equivalents
HK$22.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Cash Equivalents
$98m
CAGR 3-Years
-41%
CAGR 5-Years
53%
CAGR 10-Years
5%

See Also

What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Cash Equivalents?
Cash Equivalents
1.7B HKD

Based on the financial report for Jun 30, 2024, Beijing Tong Ren Tang Chinese Medicine Co Ltd's Cash Equivalents amounts to 1.7B HKD.

What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
13%

Over the last year, the Cash Equivalents growth was -6%. The average annual Cash Equivalents growth rates for Beijing Tong Ren Tang Chinese Medicine Co Ltd have been -4% over the past three years , 33% over the past five years , and 13% over the past ten years .

Back to Top